Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David Shackelford

2394 Sodium-Glucose Transporter 2 Is a Novel Diagnostic and Therapeutic Target for Early-Stage Lung Adenocarcinoma

Journal of Clinical and Translational Science
Medicine
2018English

Related publications

DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

DNA Hypomethylation-Related Overexpression of SFN, GORASP2 and ZYG11A Is a Novel Prognostic Biomarker for Early Stage Lung Adenocarcinoma

Oncotarget
Oncology
2019English

ARL4C Is Associated With Initiation and Progression of Lung Adenocarcinoma and Represents a Therapeutic Target

Cancer Science
Cancer ResearchMedicineOncology
2020English

LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through?

Anaesthesia
AnesthesiologyPain Medicine
2019English

Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through? A Reply

Anaesthesia
AnesthesiologyPain Medicine
2019English

Matrix Metalloproteinase 11 as a Potential Therapeutic Target in Lung Adenocarcinoma

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

Early Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes: Study Based on Continuous Glucose Monitoring

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy